Keeping Track: Keytruda Adds Two New Uses, Furoscix ‘Patch Pump’ Gets A CRL, And Nightstar Nabs An RMAT
The latest drug development news and highlights from our US FDA Performance Tracker.
You may also be interested in...
The company announced interim results of the FREEDOM-HF study showing nearly $18,000 in savings per heart failure patient.
Keeping Track: J&J Amivantamab, Infectious Disease Agents From Iterum, VBI And Atox Submitted; Another Furoscix CRL
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
The latest application submission news and highlights from the Pink Sheet’s US FDA Performance Tracker.